Pear Therapeutics, Inc. (“Pear”) has built the first end-to-end platform for prescription digital therapeutics (PDTs), which are FDA-authorized, clinician-prescribed, and payor-reimbursed software ...

Digital therapeutic company Pear announced its plans to go public via a $1.6 billion special purpose acquisition company (SPAC) merger with Thimble Point Acquisition Corp. The new combined company ...

4 Cast Set for FRIGID New York's World Premiere Of FALLING OUT: A New Musical At UNDER St. Marks Hailed as "bizarre and brilliant," Ionesco's THE BALD SOPRANO begins The Pearl's 28th season. Praised ...

BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), ...

Business Combination includes up to $276 million of funds held in Thimble Point’s trust account and a $125 million upsized private investment in public equity (the “PIPE”) Fully committed PIPE ...